Evidence map›Paper›PMID 37186228›Full record

ArticleMicrobiologyOpen2023

High prevalence of bla

Hanna Woksepp, Fagimba Camara, Jonas Bonnedahl

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in MicrobiologyOpen, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Occurrence of ESBL- and AmpC-ProducingAntibiotics (Basel, Switzerland) · 2023
    Article
  4. High prevalence of blaMicrobiologyOpen · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Hanna WokseppDepartment of Research, Region Kalmar County, Kalmar, Sweden.ORCID 0000-0002-1707-2655
Fagimba CamaraDepartment of Wildlife Management, Abuko, The West African Birds Study, Association (WABSA), Serrekunda, Gambia.
Jonas BonnedahlDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
African Wildlife Foundation · USLinköping University · SELinnaeus University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One hundred fecal samples from hooded vultures in the Gambia (Banjul area) were investigated for the presence of bacteria with extended-spectrum cephalosporin- (ESBL/AmpC), carbapenemases, and colistin resistance. No Enterobacteriales carrying carbapenemases or resistance against colistin were detected. Fifty-four ESBL-producing Escherichia coli and five ESBL-producing Klebsiella pneumoniae isolates were identified in 52 of the samples, of which 52 E. coli and 4 K. pneumoniae yielded passed sequencing results. Fifty of the E. coli had ESBL phenotype and genotype harboring bla

Indexed as

Escherichia coliEscherichia coli InfectionsAnimalsAnti-Bacterial Agentsbeta-LactamasesBirdsColistinEndangered SpeciesGambiaHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsPrevalenceAnti-Bacterial Agentsbeta-LactamasesColistinantibiotic resistanceenvironmental microbiologyinfectious agentsmicrobial ecologymicrobiological-based health strategies

Identifiers

PMID37186228
PMCPMC10035410
OpenAlexW4360611222

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read51
identifiers read3
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.